How govt incentives fuelled growth in cancer drug industry

The NBR has exempted cancer drug production from VAT and waived import duties on raw materials and machinery, making it cheaper for companies to manufacture oncology drugs domestically.

from The Business Standard https://ift.tt/oEPwxbl